The Commonwealth of Australia is weighing a bid to strike out Otsuka Pharmaceutical’s defence as the government seeks lost subsidies after an almost seven-year long patent dispute over the antipsychotic drug, Abilify.
Generic Health has shaved two percent off the $25 million damages awarded pharmaceutical giant Bayer in a patent infringement case over Bayer’s blockbuster oral contraceptive, Yasmin, but the discount is a far cry from the 15 percent it sought on appeal.
A group representing patent and trade mark lawyers is seeking to intervene in a high-stakes appeal over computer software patents.
Aristocrat Technologies has hit the jackpot in its bid for discovery to determine whether it has claims against rival Ainsworth for stealing its confidential information and using it to design a competing slot machine.
A Federal Court judge has put ASIC’s first fees for no service case, brought against two units of National Australia Bank’s wealth management division, on an expedited timetable, saying the case was not new territory for the bank.
The defendants in a shareholder class action over QRxPharma’s alleged failure to disclose problems with regulatory approval for its painkiller Moxduo have won access to information on class members’ financial brokers.
An international IP dispute between the Royal Australian Mint and its Canadian counterpart over a patent for printed commemorative coins has settled, three months after Australia revealed its “knockout claim” in the case.
A judge has struck out part of a class action against the Commonwealth Bank of Australia that alleges it kept investors in the dark about deficiencies in its systems for monitoring money laundering and terrorism financing risks, saying it wasn’t clear what the bank was expected to disclose.
The company that manufactures Botox alternatives has denied infringing on Allergan’s Botox trade mark, telling a court Wednesday its use of the word was for comparative purposes only.
The Commonwealth Bank of Australia is seeking to strike out portions of a shareholder class action over allegedly lax anti-money laundering and anti-terrorism financing controls it calls a “vague penumbra” that leaves the bank in the dark about the case against it.